Clovis Oncology Inc
Change company Symbol lookup
Select an option...
CLVS Clovis Oncology Inc
NVMI Nova Measuring Instruments Ltd
OKTA Okta Inc
APD Air Products and Chemicals Inc
DUK Duke Energy Corp
NKE Nike Inc
AAPL Apple Inc
VXRT Vaxart Inc
VIGI Vanguard International Dividend Appreciation Index Fund ETF Shares
VIG Vanguard Dividend Appreciation Index Fund ETF Shares
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company’s product Rubraca (rucaparib), an oral small molecule inhibitor of poly adenosine diphosphate (ADP)-ribose polymerase (PARP), is marketed in the United States for two indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The Company also provides Lucitanib, which is an investigational, oral, potent inhibitor of the tyrosine kinase activity of vascular endothelial growth factor receptors one through three (VEGFR1-3), platelet-derived growth factor receptors alpha and beta, and fibroblast growth factor receptors one through three (FGFR1-3).

Premarket

Last Trade
Delayed
$4.98
0.08 (1.63%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$4.90
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
16,600

10-day average volume:
4,633,086
16,600
  • Prev Close
    4.90
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    4.6M
  • Last (time)
    3:59p ET 08/11/20
  • Last (size)
    600
  • 52-Wk Range
    2.93 - 17.37
    LowHigh
  • (10/28/19 - 12/02/19)
    67.24%
  • 130.6%
  • Market Cap
    432.2M
  • Shares Outstanding
    88.2M
  • -6.07
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.4
  • 44.76
  • (% of float 07/31/20)
    39.24

Latest News

August 06, 2020
4:05 pm ET
BusinessWire
August 05, 2020
8:05 am ET
BusinessWire
July 30, 2020
11:33 am ET
Zacks
July 23, 2020
8:00 am ET
BusinessWire
July 22, 2020
8:51 am ET
Globe Newswire
July 08, 2020
8:40 am ET
PR Newswire
June 23, 2020
8:45 am ET
PR Newswire
June 22, 2020
9:01 am ET
PR Newswire
June 17, 2020
8:00 am ET
BusinessWire
June 10, 2020
4:05 pm ET
BusinessWire
May 28, 2020
8:00 am ET
BusinessWire
May 27, 2020
8:30 am ET
PR Newswire
May 21, 2020
4:10 pm ET
BusinessWire
May 18, 2020
8:05 pm ET
BusinessWire
4:02 pm ET
BusinessWire
May 15, 2020
2:30 pm ET
BusinessWire
April 27, 2020
6:26 am ET
MarketWatch
6:26 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.